Skip to search formSkip to main contentSkip to account menu

recurrent gastric cancer

Known as: gastric cancer, recurrent, Recurrent Cancer of Stomach, Recurrent Gastric Carcinoma 
The reemergence of gastric carcinoma after a period of remission.
National Institutes of Health

Related topics

Related topics

10 relations
Epithelial CellsEpitheliumGastric mucosaGastrointestinal system

Broader (1)

Malignant neoplasm of stomach recurrent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
BACKGROUND The efficacy and safety of the combination of capecitabine (X) and cisplatin (P) in the treatment of advanced gastric… 
2004
2004
Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)
Purpose: The Japanese Foundation for Multidisciplinary Treatment of Cancer conducted a Phase I study of a novel oral fluorouracil… 
2003
2003
Evaluation of 18 F-FDG PET in Patients with Advanced , Metastatic , or Recurrent Gastric Cancer
1Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; 2Department of… 
2003
2003
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects
BackgroundS-1 (TS-1®) is a novel oral anticancer drug. Because of the excellent results of phase II studies, we continued to… 
2002
2002
Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
The therapeutic efficacy of low dose administration of 5-fluorouracil (5-FU) and cisplatin (CDDP) (low dose FP) has been reported… 
Review
2002
Review
2002
Use of stents in the palliative treatment of malignant gastric outlet and duodenal obstruction.
AIM To evaluate the efficacy of stenting in the palliation of malignant duodenal and gastric outlet obstruction. MATERIALS AND… 
Highly Cited
1999
Highly Cited
1999
[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer was performed to… 
Highly Cited
1999
Highly Cited
1999
Significant Correlation between Serum Level of Hepatocyte Growth Factor and Progression of Gastric Carcinoma
Abstract. Hepatocyte growth factor (HGF) can promote proliferation of many types of tumor cells including gastric cancer cells… 
1998
1998
5T4 oncofetal antigen in gastric carcinoma and its clinical significance
Objective To evaluate the role of 5T4 antigen in gastric cancer progression and prognosis. Design A prospective study of 5T4… 
Review
1987
Review
1987
Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)